Wipfli Financial Advisors’s Inspire Medical Systems INSP Stock Holding History

Wipfli Financial Advisors’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$6K	Buy	+33	New	+$6.63K	﹤0.01%	2021

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wipfli Financial Advisors's INSP Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Inspire Medical Systems (INSP) in Q3 2022: 33 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2021 among its holdings.

301 funds tracked by Wall St. Rank hold INSP as of Q3 2022.

Wipfli Financial Advisors held 33 shares of Inspire Medical Systems worth $6K as of Q3 2022.
Inspire Medical Systems was a new Wipfli Financial Advisors position in Q3 2022.
Inspire Medical Systems made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2021 holding.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.